Assertio Holdings, Inc. Announces Leadership Transition
Dan Peisert Stepping Down as CEO
Board member Heather Mason Appointed Interim CEO
LAKE FOREST, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ:ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, announced today that Dan Peisert is stepping down as the Company’s Chief Executive Officer. The Board has appointed Heather Mason, currently an independent director of the Company and Chair of its Nominating and Corporate Governance Committee, to serve as interim CEO as the Company conducts a search for a permanent chief executive.
Related news for (ASRT)
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
- Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
- assertio holdings, inc. reports inducement grants under nasdaq listing rule 5635(c)(4)
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)